Masimo has received a go-ahead from its board of directors to carve out its consumer-focused businesses, slimming itself down to focus on professional patient monitoring devices and telehealth ...

On March 22, 2024, Masimo MASI Corporation (NASDAQ NDAQ: MASI, $144.91, Market Capitalisation: $7.7 billion), a global leader in non-invasive monitoring technologies and audio products, announced that ...

Masimo (MASI +4%) is making a strong move following news late Friday its board authorized management to evaluate a proposed separation of its consumer business. MASI also reaffirmed its Q1 and FY24 ...

Files Revised Definitive Proxy Materials and Mails Letter to Stockholders Urges Stockholders to Vote “FOR” Only Masimo’s Director Nominees, Joe Kiani and Christopher Chavez, on the Updated GOLD Proxy ...

Joe Kiani Chairman/CEO Masimo Corp. Masimo Corp. has postponed its July 25 shareholder vote that will determine control of the medical device maker and the future of founder Joe Kiani. Activist ...

Masimo has had a lot of distractions in the past couple years, between its high-profile patent battle against Apple plus tensions between CEO Joe Kiani and the board. In March, the company revealed ...

Medical tech company Masimo (NASDAQ:MASI) reported Q1 CY2025 results , but sales fell by 24.5% year on year to $372 million. The company expects the full year’s revenue to be around $1.52 billion, ...

Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for innovative technology and research and development (R&D) efforts. The optimism, ...

Masimo (MASI) is back in focus after recent trading left the shares around US$138.92, with returns that differ sharply across time frames, from a small move over the past month to a deeper decline ...

A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a patent on blood oxygen monitoring technology. Reuters reports that the jury ...